bl-b01d1
Showing 1 - 16 of 16
Cervical Cancer Trial in Beijing (BL-B01D1, SI-B003)
Not yet recruiting
- Cervical Cancer
- BL-B01D1
- SI-B003
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Aug 16, 2023
Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)
Not yet recruiting
- Small Cell Lung Cancer
- BL-B01D1
- SI-B003
-
Changchun, Jilin, ChinaJilin Cancer Hospital
Jun 21, 2023
Head and Neck Squamous Cell Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- BL-B01D1
- SI-B003
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 17, 2023
Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)
Not yet recruiting
- Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
- BL-B01D1
- SI-B003
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 12, 2023
Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)
Not yet recruiting
- Urothelial Carcinoma
- BL-B01D1
- SI-B003
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 27, 2023
Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- BL-B01D1
-
Port Saint Lucie, Florida
- +1 more
Aug 11, 2023
Nasopharyngeal Carcinoma Trial in Guangzhou (BL-B01D1, capecitabine, gemcitabine)
Not yet recruiting
- Nasopharyngeal Carcinoma
- BL-B01D1
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 31, 2023
Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)
Not yet recruiting
- Esophageal Cancer
- +2 more
- SI-B003
- BL-B01D1
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Aug 22, 2023
Gynecological Malignant Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)
Not yet recruiting
- Gynecological Malignant Tumor
- Solid Tumor
- BL-B01D1
-
Shanghai, Shanghai, ChinaFudan University ShangHai Cancer Center
Apr 9, 2023
NSCLC Trial in Shanghai (BL-B01D1, Osimertinib Mesylate Tablets)
Not yet recruiting
- Non-small Cell Lung Cancer
- BL-B01D1
- Osimertinib Mesylate Tablets
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
May 25, 2023
Urinary System Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)
Not yet recruiting
- Urinary System Tumor
- Solid Tumor
- BL-B01D1
-
Shanghai, Shanghai, ChinaFudan University ShangHai Cancer Center
Mar 26, 2023
Locally Advanced or Metastatic Urinary Tumors, Other Solid Tumors Trial in Beijing (BL-B01D1)
Recruiting
- Locally Advanced or Metastatic Urinary Tumors
- Other Solid Tumors
- BL-B01D1
-
Beijing, Beijing, China
- +3 more
Jan 11, 2023
NSCLC, Nasopharyngeal Carcinoma Trial in China (BL-B01D1, SI-B003)
Not yet recruiting
- Non-small Cell Lung Cancer
- Nasopharyngeal Carcinoma
- BL-B01D1
- SI-B003
-
Chongqing, Chongqing, China
- +15 more
Jul 13, 2023
Breast Cancer, Solid Tumor Trial in Shanghai (BL-B01D1)
Recruiting
- Breast Cancer
- Solid Tumor
- BL-B01D1
-
Shanghai, Shanghai, ChinaFudan University Cancer Hospital
Jul 20, 2022
Gastrointestinal Tumor Trial in Beijing (BL-B01D1)
Recruiting
- Gastrointestinal Tumor
- BL-B01D1
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Feb 21, 2022
Locally Advanced or Metastatic Solid Tumor Trial in Guanzhou (BL-B01D1)
Recruiting
- Locally Advanced or Metastatic Solid Tumor
- BL-B01D1
-
Guanzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jan 4, 2022